Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neutralizing antibodies in multiple sclerosis patients treated with 375 micrograms interferon-beta-1b.
Durelli L, Barbero P, Cucci A, Ferrero B, Ricci A, Contessa G, De Mercanti S, Ripellino P, Lapuma D, Viglietta E, Bergui M, Versino E, Clerico M; OPTIMS Trial NAb Sub-Study Group. Durelli L, et al. Among authors: contessa g. Expert Opin Biol Ther. 2009 Apr;9(4):387-97. doi: 10.1517/14712590902762781. Expert Opin Biol Ther. 2009. PMID: 19278300 Clinical Trial.
Interferon-beta1a for the treatment of multiple sclerosis.
Clerico M, Contessa G, Durelli L. Clerico M, et al. Among authors: contessa g. Expert Opin Biol Ther. 2007 Apr;7(4):535-42. doi: 10.1517/14712598.7.4.535. Expert Opin Biol Ther. 2007. PMID: 17373904 Review.
Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose.
Cucci A, Barbero P, Clerico M, Ferrero B, Versino E, Contessa G, Demercanti S, Viglietta E, Di Liberto A, Vai AG, Durelli L. Cucci A, et al. Among authors: contessa g. J Neuroimmunol. 2010 Sep 14;226(1-2):150-7. doi: 10.1016/j.jneuroim.2010.05.038. Epub 2010 Jun 23. J Neuroimmunol. 2010. PMID: 20573405 Clinical Trial.
Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.
Lugaresi A, Florio C, Brescia-Morra V, Cottone S, Bellantonio P, Clerico M, Centonze D, Uccelli A, di Ioia M, De Luca G, Marcellusi A, Paolillo A; BRIDGE study group. Lugaresi A, et al. BMC Neurol. 2012 Mar 5;12:7. doi: 10.1186/1471-2377-12-7. BMC Neurol. 2012. PMID: 22390218 Free PMC article. Clinical Trial.
Dexrazoxane for rapid extended livedo reticularis-like skin reaction due to systemic epirubicin diffusion during transcatheter arterial chemoembolization procedure for hepatocellular carcinoma.
Giampreti A, Lucà M, Gallo M, Baldan A, Eleftheriou G, Schranz M, Contessa G, Faraoni L, Butera R, Fagiuoli S, Bacis G. Giampreti A, et al. Among authors: contessa g. J Cancer Res Ther. 2022 Dec;18(Supplement):S501-S506. doi: 10.4103/jcrt.JCRT_574_20. J Cancer Res Ther. 2022. PMID: 36511016 Free article.
42 results